Merck Launches Online Platform Fertility.com
Merck Launches Online Platform Fertility.com
PR74235
DARMSTADT, Germany, July 3, 2018 /PRNewswire=KYODO JBN/ --
Not intended for U.S. based media
Fertility.com is the gateway to two online portals:
- Offering the latest scientific information to healthcare professionals in
the advancing field of fertility
- Supporting women, men and couples who are looking for information about
fertility and/or undergoing fertility treatment
(Photo: https://mma.prnewswire.com/media/713837/Merck_Fertility_com.jpg )
(Photo: https://mma.prnewswire.com/media/713838/Fertility_com.jpg )
Merck, a leading science and technology company, today announces the launch
of the new online portal fertility.com. Fertility.com is the entrance to access
two unique and bespoke portals:
Fertility.com/hcp; developed for fertility Healthcare Professionals (HCPs)
Fertility.com/support; created for women, men and couples who are looking for
information about fertility and/or are undergoing fertility treatment
The Healthcare Professional Portal (fertility.com/hcp) offers a wide range of
resources relevant to physicians' daily practice. On the portal, healthcare
professionals can find key medical and scientific content. This includes the
latest news, publications and developments in the field of fertility as well as
expert opinion videos and educational materials. The portal also provides the
opportunity to discover more about Merck's therapeutics, technologies and
services.
The Patient Support Portal (fertility.com/support) has been created to
provide a profound source of information for women, men and couples who are
trying or have been trying to conceive. The portal is designed to support
patients at every step of their fertility journey, including educational
materials that help them understand fertility and treatment options. They can
also find lifestyle advice to improve their chances for success.
Fertility.com is designed with convenience and easy navigation in mind,
ensuring that patients and physicians can easily access the information they
need, anytime and everywhere. This new online platform demonstrates Merck's
commitment to continuing to support people trying to conceive, whilst also
offering HCPs a scientific platform with the latest advances in reproductive
medicine.
All Merck Press Releases are distributed by e-mail at the same time they
become available on the Merck Website. Please go to
http://www.merckgroup.com/subscribe to register online, change your selection
or discontinue this service.
About Merck
Merck is a leading science and technology company in healthcare, life
science and performance materials. Almost 53,000 employees work to further
develop technologies that improve and enhance life - from biopharmaceutical
therapies to treat cancer or multiple sclerosis, cutting-edge systems for
scientific research and production, to liquid crystals for smartphones and LCD
televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical
company. The founding family remains the majority owner of the publicly listed
corporate group. Merck holds the global rights to the Merck name and brand. The
only exceptions are the United States and Canada, where the company operates as
EMD Serono, MilliporeSigma and EMD Performance Materials.
(Logo: http://mma.prnewswire.com/media/472778/Merck_Logo.jpg )
Your Contact: Dr. Raphaela Farrenkopf, +49-6151-72-2274
SOURCE: Merck
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。